Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Researchers.
Institutions.
- Address and mission.
- Equipment/Knowhow.
- Staff.
- Projects.
- Publications.
- Advised theses.
- Project partners.
- Sponsors.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Department of Internal Medicine

Division of Oncology

Publications

2023.
2022.
2021.
2020.
2019.
2018.
2017.
2016.
2015.
2014.
2013.
<2012.

SCI/PUBMED listed | all typs of publications | all by year and first author | MUG authors |

** = Publications listed in SCI/SSCI/Pubmed

Full paper/article (Journal)

** Al-Zoughbi, W; Pichler, M; Gorkiewicz, G; Guertl-Lackner, B; Haybaeck, J; Jahn, SW; Lackner, C; Liegl-Atzwanger, B; Popper, H; Schauer, S; Nusshold, E; Kindt, AS; Trajanoski, Z; Speicher, MR; Haemmerle, G; Zimmermann, R; Zechner, R; Vesely, PW; Hoefler, G Loss of adipose triglyceride lipase is associated with human cancer and induces mouse pulmonary neoplasia.
Oncotarget. 2016; 7(23):33832-33840 Doi: 10.18632/oncotarget.9418 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Belaj, K; Pichler, M; Hackl, G; Rief, P; Eller, P; Hafner, F; Brodmann, M; Gary, T Association of the Derived Neutrophil-Lymphocyte Ratio With Critical Limb Ischemia.
Angiology. 2016; 67(4):350-354 Doi: 10.1177/0003319715590701
Web of Science PubMed FullText FullText_MUG

** Belic, J; Koch, M; Ulz, P; Auer, M; Gerhalter, T; Mohan, S; Fischereder, K; Petru, E; Bauernhofer, T; Geigl, JB; Speicher, MR; Heitzer, E mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA.
Adv Exp Med Biol. 2016; 924:147-155 Doi: 10.1007/978-3-319-42044-8_28
Web of Science PubMed FullText FullText_MUG

** Bonin, S; Donada, M; Bussolati, G; Nardon, E; Annaratone, L; Pichler, M; Chiaravalli, AM; Capella, C; Hoefler, G; Stanta, G A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients.
Tumour Biol. 2016; 37(6):7295-7303 Doi: 10.1007/s13277-015-4543-3
Web of Science PubMed FullText FullText_MUG

** Goldzweig, G; Baider, L; Andritsch, E; Rottenberg, Y Hope and social support in elderly patients with cancer and their partners: an actor-partner interdependence model.
Future Oncol. 2016; 12(24):2801-2809 Doi: 10.2217/fon-2016-0267
Web of Science PubMed FullText FullText_MUG

** Hatzl, S; Geiger, O; Kuepper, MK; Caraffini, V; Seime, T; Furlan, T; Nussbaumer, E; Wieser, R; Pichler, M; Scheideler, M; Nowek, K; Jongen-Lavrencic, M; Quehenberger, F; Wölfler, A; Troppmair, J; Sill, H; Zebisch, A Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP.
Cancer Res. 2016; 76(12):3644-3654 Doi: 10.1158/0008-5472.CAN-15-3049 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Kainhofer, V; Smolle, MA; Szkandera, J; Liegl-Atzwanger, B; Maurer-Ertl, W; Gerger, A; Riedl, J; Leithner, A The width of resection margins influences local recurrence in soft tissue sarcoma patients.
Eur J Surg Oncol. 2016; 42(6):899-906 Doi: 10.1016/j.ejso.2016.03.026
Web of Science PubMed FullText FullText_MUG

** Kammerer, S; Jahn, SW; Winter, E; Eidenhammer, S; Rezania, S; Regitnig, P; Pichler, M; Schreibmayer, W; Bauernhofer, T Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistry.
J Clin Pathol. 2016; 69(12):1116-1121 Doi: 10.1136/jclinpath-2016-203798 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Kammerer, S; Sokolowski, A; Hackl, H; Platzer, D; Jahn, SW; El-Heliebi, A; Schwarzenbacher, D; Stiegelbauer, V; Pichler, M; Rezania, S; Fiegl, H; Peintinger, F; Regitnig, P; Hoefler, G; Schreibmayer, W; Bauernhofer, T KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients.
Oncotarget. 2016; 7(51):84705-84717 Doi: 10.18632/oncotarget.13224 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Kanlikilicer, P; Rashed, MH; Bayraktar, R; Mitra, R; Ivan, C; Aslan, B; Zhang, X; Filant, J; Silva, AM; Rodriguez-Aguayo, C; Bayraktar, E; Pichler, M; Ozpolat, B; Calin, GA; Sood, AK; Lopez-Berestein, G Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells.
Cancer Res. 2016; 76(24):7194-7207 Doi: 10.1158/0008-5472.CAN-16-0714 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.
Tumour Biol. 2016; 37(1):361-368 Doi: 10.1007/s13277-015-3805-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Ling, H; Pickard, K; Ivan, C; Isella, C; Ikuo, M; Mitter, R; Spizzo, R; Bullock, M; Braicu, C; Pileczki, V; Vincent, K; Pichler, M; Stiegelbauer, V; Hoefler, G; Almeida, MI; Hsiao, A; Zhang, X; Primrose, J; Packham, G; Liu, K; Bojja, K; Gafà, R; Xiao, L; Rossi, S; Song, JH; Vannini, I; Fanini, F; Kopetz, S; Zweidler-McKay, P; Wang, X; Ionescu, C; Irimie, A; Fabbri, M; Lanza, G; Hamilton, SR; Berindan-Neagoe, I; Medico, E; Mirnezami, A; Calin, GA; Nicoloso, MS The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.
Gut. 2016; 65(6):977-989 Doi: 10.1136/gutjnl-2015-309372 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Lipp, RW; Kump, PK Recent therapy options of gastrointestinal neuroendocrine tumours
AUST J CLIN ENDOCR M. 2016; 9(1): 7-10. [OPEN ACCESS]
Web of Science

** Mayr, C; Wagner, A; Loeffelberger, M; Bruckner, D; Jakab, M; Berr, F; Di Fazio, P; Ocker, M; Neureiter, D; Pichler, M; Kiesslich, T The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells.
Oncotarget. 2016; 7(1):745-758 Doi: 10.18632/oncotarget.6378 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Meggiolaro, E; Berardi, MA; Andritsch, E; Nanni, MG; Sirgo, A; Samorì, E; Farkas, C; Ruffilli, F; Caruso, R; Bellé, M; Juan Linares, E; de Padova, S; Grassi, L Cancer patients' emotional distress, coping styles and perception of doctor-patient interaction in European cancer settings.
Palliat Support Care. 2016; 14(3):204-211 Doi: 10.1017/S1478951515000760
Web of Science PubMed FullText FullText_MUG

** Ohtsuka, M; Ling, H; Ivan, C; Pichler, M; Matsushita, D; Goblirsch, M; Stiegelbauer, V; Shigeyasu, K; Zhang, X; Chen, M; Vidhu, F; Bartholomeusz, GA; Toiyama, Y; Kusunoki, M; Doki, Y; Mori, M; Song, S; Gunther, JR; Krishnan, S; Slaby, O; Goel, A; Ajani, JA; Radovich, M; Calin, GA H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer.
EBioMedicine. 2016; 13(3):113-124 Doi: 10.1016/j.ebiom.2016.10.026 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Pehserl, AM; Ress, AL; Stanzer, S; Resel, M; Karbiener, M; Stadelmeyer, E; Stiegelbauer, V; Gerger, A; Mayr, C; Scheideler, M; Hutterer, GC; Bauernhofer, T; Kiesslich, T; Pichler, M Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells.
Int J Mol Sci. 2016; 17(12): Doi: 10.3390/ijms17122011 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Popper, HH; Gruber-Mosenbacher, U; Hutarew, G; Hochmair, M; Absenger, G; Brcic, L; Mullauer, L; Dekan, G; Setinek, U; Krenbek, D; Vesely, M; Pirker, R; Hilbe, W; Kolb, R; Webersinke, G; Hernler, T; Pall, G; Lax, S; Mohn-Staudner, A Recommendations of the Austrian Working Group on Pulmonary Pathology and Oncology for predictive molecular and immunohistochemical testing in non-small cell lung cancer
MEMO-MAG EUR MED ONC. 2016; 9(4): 191-200. Doi: 10.1007/s12254-016-0297-x
Web of Science FullText FullText_MUG

** Prochazka, KT; Melchardt, T; Posch, F; Schlick, K; Deutsch, A; Beham-Schmid, C; Weiss, L; Gary, T; Neureiter, D; Klieser, E; Greil, R; Neumeister, P; Egle, A; Pichler, M NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Br J Cancer. 2016; 115(10):1264-1272 Doi: 10.1038/bjc.2016.325 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Rezania, S; Kammerer, S; Li, C; Steinecker-Frohnwieser, B; Gorischek, A; DeVaney, TT; Verheyen, S; Passegger, CA; Tabrizi-Wizsy, NG; Hackl, H; Platzer, D; Zarnani, AH; Malle, E; Jahn, SW; Bauernhofer, T; Schreibmayer, W Overexpression of KCNJ3 gene splice variants affects vital parameters of the malignant breast cancer cell line MCF-7 in an opposing manner.
BMC Cancer. 2016; 16(1):628-628 Doi: 10.1186/s12885-016-2664-8 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Rief, P; Pichler, M; Raggam, R; Hafner, F; Gerger, A; Eller, P; Brodmann, M; Gary, T The AST/ALT (De-Ritis) ratio: A novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.
Medicine (Baltimore). 2016; 95(24):e3843-e3843 Doi: 10.1097/MD.0000000000003843 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Schnedl, WJ; Kalmar, P; Wallner-Liebmann, SJ; Reiter, G; Mangge, H; Lipp, RW Anomaly of the inferior vena cava and lactose malabsorption
PHLEBOLOGIE. 2016; 45(1): 36-39. Doi: 10.12687/phleb2285-1-2016
Web of Science FullText FullText_MUG

** Stotz, M; Liegl-Atzwanger, B; Posch, F; Mrsic, E; Thalhammer, M; Stojakovic, T; Bezan, A; Pichler, M; Gerger, A; Szkandera, J Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection.
PLoS One. 2016; 11(7):e0159448-e0159448 Doi: 10.1371/journal.pone.0159448 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Troppan, KT; Melchardt, T; Wenzl, K; Schlick, K; Deutsch, A; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Tränkenschuh, W; Greil, R; Neumeister, P; Egle, A; Pichler, M The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.
J Clin Pathol. 2016; 69(4):326-330 Doi: 10.1136/jclinpath-2015-203356
Web of Science PubMed FullText FullText_MUG

** Trummer, O; Langsenlehner, U; Krenn-Pilko, S; Pieber, TR; Obermayer-Pietsch, B; Gerger, A; Renner, W; Langsenlehner, T Vitamin D and prostate cancer prognosis: a Mendelian randomization study.
World J Urol. 2016; 34(4):607-611 Doi: 10.1007/s00345-015-1646-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Ulz, P; Belic, J; Graf, R; Auer, M; Lafer, I; Fischereder, K; Webersinke, G; Pummer, K; Augustin, H; Pichler, M; Hoefler, G; Bauernhofer, T; Geigl, JB; Heitzer, E; Speicher, MR Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.
Nat Commun. 2016; 7(15):12008-12008 Doi: 10.1038/ncomms12008 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Ulz, P; Gerger, A; Belic, J; Heitzer, E Potentials, challenges and limitations of a molecular characterization of circulating tumor DNA for the management of cancer patients
LABORATORIUMSMEDIZIN. 2016; 40(5): 323-334. Doi: 10.1515/labmed-2016-0049 [OPEN ACCESS]
Web of Science FullText FullText_MUG

** Urbas, R; Mayr, C; Klieser, E; Fuereder, J; Bach, D; Stättner, S; Primavesi, F; Jaeger, T; Stanzer, S; Ress, AL; Löffelberger, M; Wagner, A; Berr, F; Ritter, M; Pichler, M; Neureiter, D; Kiesslich, T Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients.
Int J Mol Sci. 2016; 17(12): Doi: 10.3390/ijms17122053 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Wibmer, C; Amrein, K; Fahrleitner-Pammer, A; Gilg, MM; Berghold, A; Hutterer, GC; Maurer-Ertl, W; Gerger, A; Leithner, A; Pichler, M; Szkandera, J Serum sclerostin levels in renal cell carcinoma patients with bone metastases.
Sci Rep. 2016; 6(4):33551-33551 Doi: 10.1038/srep33551 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Review

** Cerk, S; Schwarzenbacher, D; Adiprasito, JB; Stotz, M; Hutterer, GC; Gerger, A; Ling, H; Calin, GA; Pichler, M Current Status of Long Non-Coding RNAs in Human Breast Cancer.
Int J Mol Sci. 2016; 17(9): Doi: 10.3390/ijms17091485 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Ling, H; Krassnig, L; Bullock, MD; Pichler, M MicroRNAs in Testicular Cancer Diagnosis and Prognosis.
Urol Clin North Am. 2016; 43(1):127-134 Doi: 10.1016/j.ucl.2015.08.013
Web of Science PubMed FullText FullText_MUG

** Mayr, C; Beyreis, M; Wagner, A; Pichler, M; Neureiter, D; Kiesslich, T Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers.
Biomed Res Int. 2016; 2016(12):4805270-4805270 Doi: 10.1155/2016/4805270 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Perakis, SO; Thomas, JE; Pichler, M Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
Adv Exp Med Biol. 2016; 937(4):183-204 Doi: 10.1007/978-3-319-42059-2_10
Web of Science PubMed FullText FullText_MUG

** Seles, M; Hutterer, GC; Kiesslich, T; Pummer, K; Berindan-Neagoe, I; Perakis, S; Schwarzenbacher, D; Stotz, M; Gerger, A; Pichler, M Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.
Int J Mol Sci. 2016; 17(4):573-573 Doi: 10.3390/ijms17040573 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Speicher, MR; Gerger, A; Hoefler, G Liquid biopsies. A multidisciplinary challenge for human geneticists, oncologists, and pathologists
MED GENET-BERLIN. 2016; 28(2): 245-250. Doi: 10.1007/s11825-016-0090-6 [OPEN ACCESS]
Web of Science FullText FullText_MUG

** Zebisch, A; Hatzl, S; Pichler, M; Wölfler, A; Sill, H Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs.
Int J Mol Sci. 2016; 17(12): Doi: 10.3390/ijms17122080 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Belic, J; Heitzer, E; Ulz, P; Auer, M; Fischereder, K; Bauernhofer, T; Geigl, JB; Speicher, MR Analysis of ctDNA using the mFastSeqS and plasma-Seq methods for screening and therapy monitoring in prostate cancer patients
CLIN CANCER RES. 2016; 22: -Meeting of the American-Association-for-Cancer-Research (AACR) Precision Medicine Series - Integrating Clinical Genomics and Cancer Therapy; JUN 13-16, 2015; Salt Lake, UT. Doi: 10.1158/1557-3265.PMSCLINGEN15-PR05 [Oral Communication]
Web of Science FullText FullText_MUG

** Beyer-Westendorf, J; Kreutz, R; Posch, F; Ay, C The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts decline in renal function over time in patients with atrial fibrillation and chronic kidney disease
EUR HEART J. 2016; 37: 604-604.-Congress of the European-Society-of-Cardiology (ESC); AUG 27-31, 2016; Rome, ITALY. [Oral Communication]
Web of Science

** Cheli, S; Baider, L; Goldzweig, G; Andritsch, E; Gany, F Mediterrean Bridges and Drifts: The European Migrant Crisis and the Role of Psycho-oncology
PSYCHO-ONCOLOGY. 2016; 25(SP. S3):90-91.Dublin,Ireland. [Oral Communication]
Web of Science

** Deutsch, AJA; Rinner, B; Pichler, M; Fechter, K; Greinix, HT; Wang, CG; Beham-Schmid, C; Neumeister, P; NR4A3 Suppresses Lymphomagenesis In Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1.
BLOOD. BLOOD128: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego, CA, DEC 03-06, 2016) Doi: 10.1182/blood.V128.22.2728.2728
Web of Science FullText FullText_MUG

** Gantenbein, N;Smolle, E;Thalhammer, M;Kornprat, P;Lackner, C;Spindelboeck, W;Kump, P;Lipp, R;Haybaeck, J Are eIFs Ingredients for Neuroendocrine Tumorigenesis?
NEUROENDOCRINOLOGY. 2016; 103: 2-3.-13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease; MAR 09-11, 2016; Barcelona, SPAIN. [Poster]
Web of Science

** Gnant, M; Pfeiler, G; Dubsky, PC; Hubalek, M; Greil, R; Jakesz, R; Wette, V; Balic, M; Haslbauer, F; Melbinger-Zeinitzer, E; Bjelic-Radisic, V; Artner-Matuschek, S; Fitzal, F; Marth, C; Sevelda, P; Mlineritsch, B; Steger, GG; Manfreda, D; Exner, R; Egle, D; Bergh, J; Kainberger, F; Talbot, S; Warner, D; Fesl, C; Singer, CF The impact of adjuvant denosumab on disease-free survival: Results from 3,425 postmenopausal patients of the ABCSG-18 trial
CANCER RES. 2016; 76: -38th Annual CTRC-AACR San Antonio Breast Cancer Symposium; DEC 08-12, 2015; San Antonio, TX. Doi: 10.1158/1538-7445.SABCS15-S2-02 [Keynote lecture]
Web of Science FullText FullText_MUG

** Hammer, P; Lipp, R; Thalhammer, M; Mischinger, HJ; Kornprat, P; Puntschart, A; Uranues, S; Haybaeck, J; Krejs, G; Kump, P Impact of Early Surgery on Prognosis in Advanced Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NET)
NEUROENDOCRINOLOGY. 2016; 103: 98-98.-13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease; MAR 09-11, 2016; Barcelona, SPAIN. [Poster]
Web of Science

** Holzer, S; Hochmair, M; Filipits, M; Mohn-Staudner, A; Errhalt, P; Absenger, G; Bundalo, T; Arns, BM; Setinek, U; Mikes, R; Kolb, R; Schumacher, M; Zochbauer-Muller, S; Patocka, K; Haslbauer, F; Rudzki, J; Burghuber, OC EGFR T790M resistance mutation in NSCLC: Real-life data of Austrian patients treated with osimertinib
WIEN KLIN WOCHENSCHR. 2016; 128(19-20):769-770. [Poster]
Web of Science

** Jahn-Kuch, D When is it time to discontinue cancer treatment?
ONCOL RES TREAT. 2016; 39: 2-2. [Oral Communication]
Web of Science

** Merola, E; Pavel, ME; Panzuto, F; Capurso, G; Cicchese, N; Rinke, A; Gress, TM; Iannicelli, E; Prosperi, D; Pizzichini, P; Kump, P; Lipp, R; Partelli, S; Falconi, M; Wiedenmann, B; Delle Fave, G Functional imaging tests and CT scan: Detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up.
J CLIN ONCOL. 2016; 34(4):-Gastrointestinal Cancers Symposium; JAN 21-23, 2016; San Francisco, CA. Doi: 10.1200/jco.2016.34.4_suppl.219 [Poster]
Web of Science FullText FullText_MUG

** Riedl, J; Posch, F; Stotz, M; Bezan, A; Winder, T; Schaberl-Moser, R; Pichler, M; Stoeger, H; Gerger, A Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw370.107 [Poster]
Web of Science FullText FullText_MUG

** Rinnerthaler, G; Gampenrieder, SP; Fridrik, M; Petzer, A; Hubalek, M; Petru, E; Jager, T; Andel, J; Balic, M; Ulmer, H; Mlineritsch, B; Greil, R Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Stage 1 results of a phase II trial (AGMT MBC-6)
CANCER RES. 2016; 76: -38th Annual CTRC-AACR San Antonio Breast Cancer Symposium; DEC 08-12, 2015; San Antonio, TX. Doi: 10.1158/1538-7445.SABCS15-P1-13-10 [Poster]
Web of Science FullText FullText_MUG

** Rinnerthaler, G; Gampenrieder, SP; Voskova, D; Petzer, A; Hubalek, M; Petru, E; Hartmann, B; Andel, J; Balic, M; Melchardt, T; Mlineritsch, B; Greil, R Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Updated safety results of a phase II trial (AGMT MBC-6)
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw365.18 [Poster]
Web of Science FullText FullText_MUG

** Scheithauer, W; Prager, G; Greil, R; Mlineritsch, B; Schaberl-Moser, R; Gerger, A; Langle, F; Viragos-Toth, I; Andel, J; Pichler, A; Pecherstorfer, M; Kretschmer, A; Seebacher, A; Jagdt, B; Eisterer, W; Krippl, P Secondary resectability rates observed in a multicenter randomized phase II study of modified capecitabine/ irinotecan (mXELIRI) plus bevacizumab (bev) followed by capecitabine/oxaliplatin (XELOX) plus bev or the reverse sequence in patients with metastatic colorectal cancer (mCRC)
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw370.41 [Poster]
Web of Science FullText FullText_MUG

** Schneider, C; Wallner, M; Abdellatif, M; von Lewinski, D; Pichler, M; Sedej, S; Rainer, P The anti-cancer tyrosine kinase inhibitor sorafenib reduces cardiac contractile force by reducing cardiomyocyte calcium transient amplitude
WIEN KLIN WOCHENSCHR. 2016; 128: S309-S310. [Poster]
Web of Science

** Silina, K; Petrausch, U; Posch, F; Leibl, S; Mundlein, A; Moch, H; Siebenhuner, A; Stupp, R; Riedl, J; Pestalozzi, BC; Schraml, P; Gerger, A; Winder, T Comprehensive molecular and immunological analysis to assess the tumor immune contexture in stage II and III colorectal cancer
ANN ONCOL. 2016; 27: Doi: 10.1093/annonc/mdw393.12
Web of Science FullText FullText_MUG

** Singer, CF; Filipits, M; Jahn, S; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Schmitt, M; Moinfar, F; Gnant, M Stromel co-expression of urokinase-type plasminogen activator (uPA) and plasminogen activator Inhibitor (PAI-1) protein by IHC predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer
CANCER RES. 2016; 76: -38th Annual CTRC-AACR San Antonio Breast Cancer Symposium; DEC 08-12, 2015; San Antonio, TX. Doi: 10.1158/1538-7445.SABCS15-P2-08-21 [Poster]
Web of Science FullText FullText_MUG

** Smolle, MA; Flick, H; Pichler, M; Olschewski, H; Lindenmann, J; Gerger, A Is it safe to use NSAIDs for pain control during chemical pleurodesis for malignant pleural effusion?
WIEN KLIN WOCHENSCHR. .. 2016; 128(19-20):772-773. [Poster]
Web of Science

** Winder, T; Posch, F; Asamer, E; Stotz, M; Siebenhuner, A; Schlick, K; Magnes, T; Samaras, P; Szkandera, J; Clavien, PA; Neureiter, D; Greil, R; Pestalozzi, BC; Stoeger, H; Gerger, A; Egle, A; Pichler, M An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw371.77 [Poster]
Web of Science FullText FullText_MUG

** Woitas, R; Scharnagl, H; Kleber, ME; Delgado, GE; Grammer, TB; Pichler, M; Kramer, BK; Marz, W; Stojakovic, T IMPACT OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN AND NEUTROPHIL COUNTS IN THE LUDWIGSHAFEN RISK AND CARDIOVASCULART HEALTH STUDY
ATHEROSCLEROSIS. 2016; 252: E67-E67.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA. Doi: 10.1016/j.atherosclerosis.2016.07.455 [Poster]
Web of Science FullText FullText_MUG

** Zollner-Schwetz, I; Zechner, E; Ullrich, E; Pux, C; Pichler, G; Schippinger, W; Krause, R; Leitner, E Colonization with multidrug-resistant Gram-negative bacteria in long time care facilities: prevalence and risk factors
WIEN KLIN WOCHENSCHR. 2016; 128: S387-S388. [Poster]
Web of Science

** Zweiker, D; Rosch, K; Schumacher, M; Stepan, V; Krippl, P; Bauer, N; Heine, M; Reicht, G; Zweiker, G; Watzinger, N Benefit and Risk Assessment for the Initiation of oral Anticoagulation in non-valvular Atrial Fibrillation: The Self-assessment by the Patient differs from the individual Risk Assessment by means of CHA2DS2-VASc and HASBLED Scores
WIEN KLIN WOCHENSCHR. 2016; 128: S391-S392. [Poster]
Web of Science

** Zweiker, D; Rosch, K; Schumacher, M; Stepan, V; Krippl, P; Heine, M; Reicht, G; Zweiker, G; Watzinger, N Benefit and Risk Assessment in Initiation of oral Anticoagulant in non valvularem Atrial Fibrillation: A Comparison between Self Assessment by the Patient and an individual Risk Assessment by CHA2DS2VASc and HAS-BLED Scores
WIEN KLIN WOCHENSCHR. 2016; 128: S299-S300. [Poster]
Web of Science